Find a suitable treatment for your respiratory patients with the MIMS guide to asthma and COPD preparations.
Products are presented by class, with details of the available formulations (including tablets, oral solutions and nebuliser solutions) and devices (breath-actuated inhalers [BAIs] and metered-dose inhalers [MDIs]). Compatible spacers are also listed.
Bronchodilators include short-acting anticholinergics (also known as short-acting muscarinic antagonists; SAMAs) like ipratropium and long-acting anticholinergics (long-acting muscarinic antagonists; LAMAs) such as tiotropium, as well as β2 agonists, which are similarly divided into short-acting (SABAs) such as salbutamol and long-acting (LABAs) such as salmeterol.
Anti-inflammatories are represented by inhaled corticosteroids (ICS) like beclometasone. leukotriene antagonists such as montelukast, non-steroidal anti-inflammatories like sodium cromoglicate and PDE4 inhibitors like roflumilast.
Combination products, including LAMA/LABA, LABA/ICS and SABA/SAMA formulations, are also covered.
Brand names link through to the full MIMS entries for more detailed prescribing information on each product.